Immunosuppression in Older Renal Transplant Patients

被引:0
|
作者
Jose M. Morales
Josep M. Campistol
Amado Andrés
Juan C. Herrero
机构
[1] Hospital 12 de Octubre,Renal Transplant Unit, Nephrology Department
[2] Hospital Clinic,Renal Transplant Unit
来源
Drugs & Aging | 2000年 / 16卷
关键词
Cyclosporin; Tacrolimus; Acute Rejection; Triple Therapy; Mycophenolate Mofetil;
D O I
暂无
中图分类号
学科分类号
摘要
Renal transplantation procedures in patients older than 60 years of age have clearly improved in recent years. In the cyclosporin era, graft and patient survival are good. However, older patients exhibit a higher mortality, especially from infectious and cardiovascular causes, than young patients. In this article we review the immunosuppressive treatment in older patients, analyse what drugs can be used and finally propose several immunosuppressive combinations to treat this group of patients. Currently, new immunosuppressive drugs enable more flexible immunosuppressive protocols. Nevertheless, to avoid overimmunosuppression, elderly patients should be treated with lower doses and fewer immunosuppressive drugs.
引用
下载
收藏
页码:279 / 287
页数:8
相关论文
共 50 条
  • [41] Chronic sensorimotor polyneuropathy associated with tacrolimus immunosuppression in renal transplant patients: Case reports
    Bhagavati, S.
    Maccabee, P.
    Muntean, E.
    Sumrani, N. B.
    TRANSPLANTATION PROCEEDINGS, 2007, 39 (10) : 3465 - 3467
  • [42] Recurrent IgA Nephropathy in Renal Transplant Patients Receiving a Steroid Sparing Immunosuppression Regime
    McGuinness, D. M.
    Willicombe, M.
    McLean, A. G.
    Cook, T.
    Roufosse, C.
    Taube, D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 378 - 378
  • [43] Cyclosporine-a-based immunosuppression and renal functional reserve in organ-transplant patients
    Kamar, N
    Allard, J
    Ader, JL
    Rostaing, L
    TRANSPLANTATION PROCEEDINGS, 2004, 36 (02) : 248S - 250S
  • [44] Immunosuppression does not alter the proportion of recent thymus emigrants in renal transplant patients.
    Nickel, P
    Bold, G
    Kreutzer, S
    Friebe, A
    Meisel, C
    May, G
    Volk, HD
    Reinke, P
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 221 - 221
  • [45] Enteric-coated mycophenolate sodium immunosuppression in renal transplant patients: efficacy and dosing
    Cooper, Matthew
    Salvadori, Maurizio
    Budde, Klemens
    Oppenheimer, Frederic
    Sollinger, Hans
    Zeier, Martin
    TRANSPLANTATION REVIEWS, 2012, 26 (04) : 233 - 240
  • [46] Systemic immunosuppression inhibits in-stent coronary intimal proliferation in renal transplant patients
    Lima, VC
    Arruda, JA
    Brito, FS
    Barbosa, AH
    Ribeiro, EP
    Silva, HT
    Costa, MA
    Pestana, JOM
    CIRCULATION, 2002, 106 (19) : 593 - 593
  • [47] Immunosuppression (IST) can be safely ceased during chemotherapy for PTLD in renal transplant patients
    Mollee, Peter
    Hourigan, Matthew
    Johnson, David
    Jones, Mark
    Isabel, Nikki
    Hawley, Carmel
    Marlton, Paula
    Gandhi, Maher
    Campbell, Scott
    Gill, Devinder
    BLOOD, 2007, 110 (11) : 410A - 411A
  • [48] Immunosuppression Protocols for HLA identical renal transplant recipients
    Keitel, E
    Santos, AF
    Alves, MA
    Neto, JP
    Schaefer, PG
    Bittar, AE
    Goldani, JC
    Pozza, R
    Bruno, RM
    See, D
    Garcia, CD
    Garcia, VD
    TRANSPLANTATION PROCEEDINGS, 2003, 35 (03) : 1074 - 1075
  • [49] A Surgeons' Guide to Renal Transplant Immunopathology, Immunology, and Immunosuppression
    Gaber, Lillian W.
    Knight, Richard J.
    Patel, Samir J.
    SURGICAL CLINICS OF NORTH AMERICA, 2013, 93 (06) : 1293 - +
  • [50] Update: Immunosuppression for Organ Transplant Patients
    Kniepeiss, Daniela
    Rosenkranz, Alexander R.
    Fickert, Peter
    Schemmer, Peter
    TRANSFUSIONSMEDIZIN, 2020, 10 (04) : 221 - 233